Nobilis Health Corp.
NHC.TO
TSX
| 06/30/2018 | 03/31/2018 | 12/31/2017 | 09/30/2017 | 06/30/2017 | |
|---|---|---|---|---|---|
| Net Income | -44.16% | -60.63% | -61.61% | 136.75% | -67.02% |
| Total Depreciation and Amortization | 85.47% | 95.17% | 64.97% | 38.31% | 36.51% |
| Total Amortization of Deferred Charges | 166.13% | 211.93% | -59.22% | 171.74% | 275.76% |
| Total Other Non-Cash Items | -83.99% | 349.20% | 60.76% | -121.99% | 204.87% |
| Change in Net Operating Assets | -10.33% | -101.55% | 10.51% | 772.98% | -6,351.96% |
| Cash from Operations | -97.33% | -83.88% | 77.84% | 1,002.76% | -20.52% |
| Capital Expenditure | -135.47% | 81.72% | 74.20% | -6.86% | -54.17% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -210.17% | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -46.62% | 94.56% | -172.37% | -84.34% | -54.17% |
| Total Debt Issued | 358.73% | 59.02% | -29.16% | -100.00% | -125.77% |
| Total Debt Repaid | -4.70% | -325.15% | 96.11% | 72.45% | -109.64% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1,551.88% | -173.35% | -59.99% | 40.77% | 84.05% |
| Cash from Financing | -58.15% | -192.56% | 39.48% | -325.72% | -2,101.65% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -245.60% | -89.34% | -334.03% | 520.45% | -174.71% |
